A role for mast cells in the progression of Duchenne muscular dystrophy?. Correlations in dystrophin-deficient humans, dogs, and mice

Journal of the Neurological Sciences

Volumn 122, Issue 1, 1994, Pages 44-56

  Gorospe, J Rafael M ^a   Tharp, Michael D ^b   Hinckley, John ^b   Kornegay, Joe N ^c   Hoffman, Eric P ^a  

^a Department of Molecular Genetics Human Genetics and Pediatrics ^*  (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Duchenne muscular dystrophy; Dystrophin; Mast cells

Indexed keywords

DYSTROPHIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHILD; CONTROLLED STUDY; DOG; DUCHENNE MUSCULAR DYSTROPHY; FETUS; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MAST CELL; MOUSE; MUSCLE BIOPSY; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; AVIDIN; CHILD; CHILD, PRESCHOOL; DOGS; DYSTROPHIN; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; HISTOCYTOCHEMISTRY; HUMAN; INFANT; INFANT, NEWBORN; LECTINS; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; MUSCLES; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; NECROSIS; PREGNANCY; SERINE ENDOPEPTIDASES; SUPPORT, NON-U.S. GOV'T;

EID: 0028212670     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(94)90050-7     Document Type: Article

References (71)

1. Mast cells and biogenic amines in radiation-induced pulmonary fibrosis
2. Functional regeneration in the hindlimb skeletal muscle of the mdx mouse
3. Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles
4. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide
5. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules
6. Dystrophin analysis in Duchenne muscular dystrophy: Use in fetal diagnosis and in genetic counseling
7. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface
8. Feline muscular dystrophy with dystrophin deficiency
9. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs
10. Modes of FGF release in vivo and in vitro
11. Anti-inflammatory effect of FK-506 on human skin mast cells
12. Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle
13. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists
14. Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myosclérosique
15. Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myosclérosique
16. Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myosclérosique
17. Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myosclérosique
18. Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myosclérosique
19. The mast cell
20. Integrative histochemical approach to the defect of Duchenne muscular dystrophy
21. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy
22. New insights into “The Riddle of the Mast Cells”: Microenvironmental regulation of mast cell development and phenotypic heterogeneity
23. Dystrophin deficiency causes lethal muscle hypertrophy in cats
24. Mast cell proteases
25. Duchenne muscular dystrophy
26. Duchenne dystrophy: Randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)
27. Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists
28. Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis
29. The mast cell and myofibroblast in wound healing
30. Mast cells in neuromuscular diseases
31. The animal models of Duchenne muscular dystrophy: windows on the pathophysiological consequences of dystrophin deficiency
32. Duchenne/Becker muscular dystrophy and the non-dystrophic myotonias paradigms for loss-of-function and change-of-function of gene products
33. Dystrophin: the protein product of the Duchenne muscular dystrophy locus
34. Cell and fiber-type distribution of dystrophin
35. Dystrophin characterization in muscle biopsies from Duchenne and Becker muscular dystrophy patients
36. Dolichos biflorus agglutinin (DBA) reacts selectively with mast cells in human connective tissues
37. Mechanical properties of normal and mdx mouse sarcolemma: bearing on function of dystrophin
38. Two types of human mast cells that have distinct neutral protease compositions
39. Detection of MCT and MCTC types of mast cells by immunocytochemistry using new monoclonal antitryptase and anti-chymase antibodies
40. 2 release from isolated Duchenne muscle
41. Diagnosis of mastocytosis subsets using a morphometric point counting technique
42. Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy
43. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
44. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
45. Muscular dystrophy in a litter of golden retriever dogs
46. Agents that release histamine from mast cells
47. The relationship of mast cells and their secreted products to the volume of fibrosis in posttransplant hearts
48. Routine staining procedures
49. “Sick” motor neurons
50. Duchenne muscular dystrophy: Functional ischemia reproduces its characteristic lesions
51. Decreased osmotic stability of dystrophinless muscle cells from the mdx mouse
52. Dystrophin analysis in Duchenne and Becker muscular dystrophy carriers: correlation with intracellular calcium and albumin
53. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy
54. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine
55. Dystrophin protects the sarcolemma from stresses developed during muscle contraction
56. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases
57. Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymase
58. Mast cell tryptase is a potent mitogen for cultured fibroblasts
59. Mast cells and fibrosis in compartments of lymph nodes of normal, gnotobiotic, and athymic rats
60. Nedocromil sodium modulates the function of long-term rat peritoneal mast cell cultures
61. Cyclosporine increases muscular force generation in Duchenne muscular dystrophy
62. Anti-inflammatory effect of cyclosporin A on human skin mast cells
63. Conjugated avidin binds to mast cell granules
64. Studies of connective tissue mast cell-mediated cytotoxicity
65. Increased calcium influx in dystrophic muscle
66. Canine X-linked muscular dystrophy
67. A qualitative and quantitative study of the ultrastructure of regenerating muscle fibres in Duchenne muscular dystrophy and polymyositis
68. Immunoelectron microscopic localization of dystrophin in myofibres
69. Angiotensin I conversion by human and rat chymotryptic proteinases